Higher Doses of Erythropoietin-Stimulating Agents and Hyporesponsiveness to Their Effects Are Associated with Increased Mortality among Prevalent Hemodialysis Patients

Publisher： Karger

E-ISSN： 1421-9735|36|1|29-36

ISSN： 0253-5068

Source： Blood Purification, Vol.36, Iss.1, 2013-05, pp. : 29-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Requiring Higher Doses of Erythropoietin Suggests Pregnancy in Hemodialysis Patients

By  

Nephron, Vol. 79, Iss. 4, 1998-07 ,pp. : 413-419

Karger

Access to resources Recommend Favorite

A Vitamin E-Coated Polysulfone Membrane Reduces Serum Levels of Inflammatory Markers and Resistance to Erythropoietin-Stimulating Agents in Hemodialysis Patients: Results of a Randomized Cross-Over Multicenter Trial

By  

Blood Purification, Vol. 32, Iss. 1, 2011-01 ,pp. : 7-14

Karger

Access to resources Recommend Favorite

Minor Elevation in C-Reactive Protein Levels Predicts Incidence of Erythropoiesis-Stimulating Agent Hyporesponsiveness among Hemodialysis Patients

By  

Nephron, Vol. 131, Iss. 2, 2015-0 ,pp. : 123-130

Karger

Access to resources Recommend Favorite

Hypokalemia Is Associated with Increased Mortality Rate in Chronic Hemodialysis Patients

By  

Blood Purification, Vol. 32, Iss. 4, 2011-08 ,pp. : 254-261

Karger

Access to resources Recommend Favorite

Fatigue Is Associated with Increased Risk of Mortality in Patients on Chronic Hemodialysis

By  

Nephron, Vol. 130, Iss. 2, 2015-05 ,pp. : 113-118

Karger

Access to resources Recommend Favorite